TROMSOPOROSIS: SECONDARY FRACTURE PREVENTION PROGRAM RESULTED IN HIGH ADHERENCE TO ANTI-OSTEOPOROTIC DRUGS IN TROMSO, NORWAY

被引：0
|
作者：
Andreasen, C. [1 ]
Rogli, V. G. [2 ]
Elvenes, J. [1 ]
Joakimsen, R. M. [1 ]
Borgen, T. T. [3 ]
Solberg, L. B. [4 ]
Frihagen, F. [4 ]
Nordsletten, L. [4 ]
Eriksen, E. F. [4 ]
Basso, T. [5 ]
Dahl, C. [6 ]
Omsland, T. K. [6 ]
Bjornerem, A. [1 ]
机构：
[1] Univ Hosp North Norway, Tromso, Norway
[2] Arctic Univ Norway, Tromso, Norway
[3] Hosp Drammen, Vestre Viken Hosp Trust, Drammen, Norway
[4] Oslo Univ Hosp, Oslo, Norway
[5] St Olavs Univ Hosp, Trondheim, Norway
[6] Univ Oslo, Oslo, Norway
来源：
OSTEOPOROSIS INTERNATIONAL | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P849
引用
收藏
页码：S429 / S430
页数：2
相关论文
共 35 条
  • [1] Tromsoporosis - Adherence to a Secondary Fracture Prevention Program in Tromso, Norway.
    Andreasen, Camilla
    Osima, Marit
    Rognli, Veronica G.
    Grundel, Dag E.
    Elvenes, Jan
    Knutsen, Gunnar
    Meknas, Khaled
    Joakimsen, Ragnar M.
    Borgen, Tove T.
    Solberg, Lene B.
    Frihagen, Frede
    Nordsletten, Lars
    Eriksen, Erik F.
    Basso, Trude
    Dahl, Cecilie
    Omsland, Tone K.
    Bjornerem, Ashild
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S267 - S267
  • [2] Use of anti-osteoporotic drugs in central Norway after a forearm fracture
    Hoff, Mari
    Skurtveit, Svetlana
    Meyer, Haakon E.
    Langhammer, Arnulf
    Sogaard, Anne Johanne
    Syversen, Unni
    Abrahamsen, Bo
    Schei, Berit
    ARCHIVES OF OSTEOPOROSIS, 2015, 10 (01)
  • [3] Use of anti-osteoporotic drugs in central Norway after a forearm fracture
    Mari Hoff
    Svetlana Skurtveit
    Haakon E. Meyer
    Arnulf Langhammer
    Anne Johanne Søgaard
    Unni Syversen
    Bo Abrahamsen
    Berit Schei
    Archives of Osteoporosis, 2015, 10
  • [4] IMPACT OF ADHERENCE TO ANTI-OSTEOPOROTIC DRUGS ON THE OCCURRENCE OF FRACTURES
    Belhassen, M.
    Cortet, B.
    Confavreux, C. B.
    Lamezec, L.
    Ginoux, M.
    Van Ganse, E.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S257 - S258
  • [5] Undertreatment with anti-osteoporotic drugs after hospitalization for fracture
    Panneman, MJM
    Lips, P
    Sen, SS
    Herings, RMC
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 (02) : 120 - 124
  • [6] Undertreatment with anti-osteoporotic drugs after hospitalization for fracture
    Martien J. M. Panneman
    Paul Lips
    Shuvayu S. Sen
    Ron M. C. Herings
    Osteoporosis International, 2004, 15 : 120 - 124
  • [7] COST-EFFECTIVENESS OF MULTIPLE ANTI-OSTEOPOROTIC THERAPIES FOR SECONDARY FRACTURE PREVENTION IN JAPAN
    Moriwaki, K.
    Yoshimura, M.
    Izumi, R.
    Noto, S.
    VALUE IN HEALTH, 2014, 17 (07) : A381 - A381
  • [8] The biology of fracture healing in osteoporosis and in the presence of anti-osteoporotic drugs
    Hak, David J.
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2018, 49 (08): : 1461 - 1465
  • [9] Anti-osteoporotic Drug Utilization Rates for Secondary Prevention Among Patients with Osteoporotic Fractures
    Aypak, Cenk
    Bircan, Mustafa A.
    Ozdemir, Ayse
    RAMBAM MAIMONIDES MEDICAL JOURNAL, 2022, 13 (03):
  • [10] DECREASE IN ANTI-OSTEOPOROTIC DRUGS PRESCRIPTIONS: IS THERE AN IMMEDIATE CONSEQUENCE ON HIP FRACTURE INCIDENCE?
    Briot, K.
    Maravic, M.
    Roux, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 530 - 530
1234